...
首页> 外文期刊>Cytogenetic and genome research >A Novel bold> italic>PTCH1/italic> /bold>Frameshift Mutation Leading to Nevoid Basal Cell Carcinoma Syndrome
【24h】

A Novel bold> italic>PTCH1/italic> /bold>Frameshift Mutation Leading to Nevoid Basal Cell Carcinoma Syndrome

机译:一种新颖的&粗体>&斜体> ptch1& /斜体>& /粗体>框架突变,导致Nevoid基础细胞癌综合征

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Nevoid basal cell carcinoma syndrome (NBCCS), also known as Gorlin syndrome, is a rare multisystemic autosomal dominant disorder typically presenting with cutaneous basal cell carcinomas, multiple keratocysts, and skeletal anomalies. NBCCS is caused by heterozygous mutations in the PTCH1 gene in chromosome 9q22, in the PTCH2 gene in 1p34, or the SUFU gene in 10q24.32. Here, we report on an 18-month-old boy presenting with medulloblastoma, frontal bossing, and multiple skeletal anomalies and his father who has basal cell carcinomas, palmar pits, macrocephaly, bifid ribs, calcification of falx cerebri, and a history of surgery for odontogenic keratocyst. These clinical findings were compatible with the diagnosis of NBCCS, and a novel mutation, c.1249delC; p.Gln417Lysfs*15, was found in PTCH1 causing a premature stop codon.
机译:Nevoid基础细胞癌综合征(NBCC),也称为Gorlin综合征,是一种罕见的多系统常染色体显性障碍,通常用皮肤基底细胞癌,多个角囊细胞和骨骼异常呈现。 NBCC是由染色体9Q22中PTCH1基因中的杂合酶突变引起的,在1P34的PTCH2基因中,或10Q24.32中的SUFU基因。 在这里,我们报告了一个18个月大的男孩,患有Medulloblastoma,额外凸起和多个骨骼异常以及他的父亲,他具有基础细胞癌,露跖,猕猴,Bifid肋骨,Falx Cerebri的钙化以及手术历史 用于牙突菌的角蛋白。 这些临床发现与NBCC的诊断相容,新的突变,C.1249Delc; P.GLN417LYSFS * 15,在PTCH1中发现导致过早的止脚密码子。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号